Benelyte otopina za infuziju
| Name | Benelyte otopina za infuziju |
|---|---|
| Marketing Authorisation Number | HR-H-381269131 |
| Active Substance | natrijev klorid kalijev klorid kalcijev klorid dihidrat magnezijev klorid heksahidrat natrijev acetat trihidrat glukoza hidrat |
| Composition | svaki ml otopine za infuziju sadrži 6,429 mg natrijevog klorida, 0,298 mg kalijevog klorida, 0,147 mg kalcij klorid dihidrata, 0,203 mg magenzij klorid heksahidrata, 4,082 mg natrij acetat trihidrata i 11 mg glukoza hidrata |
| Pharmaceutical Form | Otopina za infuziju |
| Manufacturer | Fresenius Kabi Polska Sp. z o.o., Kutno, Poljska |
| Marketing Authorisation Holder | Fresenius Kabi d.o.o., Radnička cesta 37a, Zagreb, Hrvatska |
| Marketing Authorisation Date | 25.10.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/23-02/83 |
| Registration Number | 381-12-01/171-23-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | B05BB02 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
